Goal 2: Reduce Human Disease

US-based Clinical Development of Innovative Medical Devices

Though innovative medical devices are often conceived of and developed in the US, US consumers are frequently the last to benefit. Innovators frequently go to market first in Europe and are now moving toward emerging countries, delaying the medical benefits available to the US population. Can the NHLBI and FDA’s CDRH, working together as sister agencies, develop strategies such as funding opportunities or collaborative regulatory science initiatives to incentivize US-based medical device development and first-in-human studies?

Tags (Keywords associated with the idea)

Voting

4 net votes
19 up votes
15 down votes
Active
Idea No. 337